A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
Titel:
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
Auteur:
Garcia-Manero, Guillermo Gaddh, Manila Platzbecker, Uwe Lindsley, R. Coleman Larson, Sarah M. Chevassut, Timothy Fenaux, Pierre Komrokji, Rami Lyons, Roger Al-Kali, Aref Jiang, Yu Bothos, John Townsley, Danielle M. Zeidan, Amer M.